In the Journals

EULAR: Identifying thrombotic, obstetric risk factors key to managing antiphospholipid syndrome

July 8, 2019
Identifying high-risk factors for thrombotic and obstetric events is crucial in managing antiphospholipid syndrome, and all women with…

Feature

Social media opens new avenue to advocacy in rheumatology

June 21, 2019
Political activism is more accessible than ever thanks to the amplification offered by social media, and rheumatologists can use social media —…

Q&A With Healio Rheumatology

Speaking the Language: Health care execs join United Rheumatology to advocate for independent practice

May 24, 2019
In the ever-changing landscape of the United States health care system, rheumatologists need a voice. They need a voice in managing the complex web…

Meeting News

Congress of Clinical Rheumatology to feature both well-known, 'off the circuit' speakers

April 30, 2019
More than 620 registered attendees from 45 states and 11 countries are traveling to Destin, Florida, this week for the 2019 Congress of Clinical…

In the Journals

Antiphospholipid syndrome affects 1 in 2,000, peak risk among elderly

April 8, 2019
Antiphospholipid syndrome has an annual incidence rate of 2.1 per 100,000, with an estimated prevalence of 50 individuals per 100,000 with a notably…

Feature

Fighting an 'invisible epidemic' during Autoimmune Disease Awareness Month

March 13, 2019
Faced with an increasing incidence and prevalence of autoimmune disease in the United States —approximately 23.5 million Americans are affected…

National Rare Disease Week goes to Washington

February 27, 2019
More than 500 patient advocates met in Washington, D.C., this week in recognition of National Rare Disease Week, where they aim to educate and lobby…

Feature

Direct-to-consumer genetic testing not ready for prime time in rheumatology

January 18, 2019
Splashy headlines in the mainstream media that proclaim advances in medicine are often not what they seem. That may be the case with a recent series…

In the Journals

Few rheumatic adverse events from immune checkpoint inhibitors require discontinuation

November 15, 2018
Researchers found that the most prevalent adverse effect linked to immune checkpoint inhibitors was inflammatory arthritis, and although most…

Meeting News

IgG antiphospholipid antibodies linked to heart attack

November 5, 2018
CHICAGO — The presence of IgG antiphospholipid antibodies is strongly and independently associated with myocardial infarction, according to…

ACR report card: Majority of states score 'C' for rheumatology care

September 4, 2018
The 2018 Rheumatic Disease Report Card: Raising the Grade on Rheumatology Care in America released today by the American College of Rheumatology…

A Diagnosis Divided

August 31, 2018
We begin with a 24-year-old previously healthy female presenting with gradual worsening — over the last few months — migraine-like…

In the Journals

Less than one-third of reproductive-age women with rheumatic disease use prescription contraception

August 28, 2018
Just 32.1% of reproductive-age women with rheumatic diseases use any kind of prescription contraception, while at the same time more than 70% use at…

Meeting News

Johns Hopkins named top hospital for rheumatology care by U.S. News & World Report

August 17, 2018
Johns Hopkins Hospital has been recognized by U.S. News & World Report’s Best Hospitals Survey as the top-ranked hospital in the country…

Healio Rheumatology launches 'Rheuminations' podcast series

July 16, 2018
Healio Rheumatology is proud to announce the launch of Rheuminations, a podcast series hosted by Adam Brown, MD, focusing on medical mysteries and…

Pregnant patients with antiphospholipid syndrome may benefit from addition of aspirin to treatment

July 6, 2017
MADRID — Pregnant patients with antiphospholipid syndrome managed with conventional treatments appear to have a high level of obstetrical…

Meeting News

Triple-therapy regimen associated with improved survival in catastrophic antiphospholipid syndrome

June 16, 2017
MADRID — A triple regimen of anticoagulation therapy, corticosteroids and plasma exchange and/or immunoglobulins was associated with reduced…

In the JournalsPerspective

EULAR publishes recommendations for women with lupus

March 9, 2017
A team of EULAR researchers published recommendations for health issues and family planning for women with lupus or antiphospholipid syndrome. …

Meeting News Coverage

Lupus anticoagulant associated with risks in patients with aPL antibodies

December 15, 2015
Most events related to antiphospholipid-positivity were not associated with the antiphospholipid antibody profile, however, an association was…

Meeting News Coverage

Upcoming ACR conference highlights advances in all fields in rheumatology

November 5, 2015
The American College of Rheumatology Annual Meeting in San Francisco begins on Nov. 7, and Healio Rheumatology will cover the event and its many…